M-TriDAP (TFA)

• UNSPSC Description:

  M-TriDAP (N-Acetylmuramyl-L-Ala-γ-D-Glu-meso-diaminopimelic acid) TFA is a NOD1/2 agoist and biological active peptide[1].

• Target Antigen:

  NOD-like Receptor (NLR)

• Type:

  Peptides

• Related Pathways:

  Immunology/Inflammation

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Others

• Assay Protocol:

  https://www.medchemexpress.com/m-tridap-tfa.html

• Solubility:

  10 mM in DMSO

• Smiles:

  CC(N[C@@H](C=O)[C@H]([C@H](O)[C@H](O)CO)O[C@H](C)C(N[C@@H](C)C(N[C@@H](C(O)=O)CCC(NC(C(O)=O)CCCC(N)C(O)=O)=O)=O)=O)=O.OC(C(F)(F)F)=O.[x]

• Molecular Weight:

  665.64 (free acid)

• References & Citations:

  [1]Wasmuth S, et al. Phenotypic Differences in Primary Murine Microglia Treated with NOD1, NOD2, and NOD1/2 Agonists. J Mol Neurosci. 2020 Apr;70(4):600-609.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported